Oxford/AstraZeneca trial data is first to suggest a vaccine prevents asymptomatic infection, which the U.K.’s leader calls an “absolutely superb” development. Source
Oxford/AstraZeneca trial data is first to suggest a vaccine prevents asymptomatic infection, which the U.K.’s leader calls an “absolutely superb” development. Source